These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2666627)

  • 21. Juvenile macular dystrophy associated with deficient activity of fatty aldehyde dehydrogenase in Sjögren-Larsson syndrome.
    Willemsen MA; Cruysberg JR; Rotteveel JJ; Aandekerk AL; Van Domburg PH; Deutman AF
    Am J Ophthalmol; 2000 Dec; 130(6):782-9. PubMed ID: 11124298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depletion of alcohol (hexanol) dehydrogenase activity in the epidermis and jejunal mucosa in Sjögren-Larsson syndrome.
    Judge MR; Lake BD; Smith VV; Besley GT; Harper JI
    J Invest Dermatol; 1990 Dec; 95(6):632-4. PubMed ID: 2250105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjögren-Larsson syndrome.
    Rizzo WB; Heinz E; Simon M; Craft DA
    Biochim Biophys Acta; 2000 Dec; 1535(1):1-9. PubMed ID: 11113626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sjögren-Larsson syndrome: biochemical defects and follow up in three cases.
    Auada MP; Taube MB; Collares EF; Tanaka AM; Cintra ML
    Eur J Dermatol; 2002; 12(3):263-6. PubMed ID: 11978568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sjögren-Larsson syndrome: technique and timing of prenatal diagnosis.
    Tabsh K; Rizzo WB; Holbrook K; Theroux N
    Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):700-3. PubMed ID: 8378019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sjögren-Larsson-like syndrome with bone dysplasia and normal fatty alcohol NAD+ oxidoreductase activity.
    Scalais E; Verloes A; Sacré JP; Piérard GE; Rizzo WB
    Pediatr Neurol; 1992; 8(6):459-65. PubMed ID: 1476577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasmalogens and fatty alcohols in rhizomelic chondrodysplasia punctata and Sjögren-Larsson syndrome.
    Malheiro AR; da Silva TF; Brites P
    J Inherit Metab Dis; 2015 Jan; 38(1):111-21. PubMed ID: 25432520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sjögren-Larsson syndrome: delta 5-and delta 6-fatty acid desaturases in skin fibroblasts.
    Avigan J; Campbell BD; Yost DA; Hernell O; Holmgren G; Jagell SF
    Neurology; 1985 Mar; 35(3):401-3. PubMed ID: 3974899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.
    Rizzo WB
    Mol Genet Metab; 2007 Jan; 90(1):1-9. PubMed ID: 16996289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adeno-associated virus vectors are able to restore fatty aldehyde dehydrogenase-deficiency. Implications for gene therapy in Sjogren-Larsson syndrome.
    Haug S; Braun-Falco M
    Arch Dermatol Res; 2005 Jun; 296(12):568-72. PubMed ID: 15834613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A very rare neurocutaneous disorder in 2 siblings: Sjögren-Larsson syndrome.
    Caglayan AO; Gumus H
    J Child Neurol; 2010 Aug; 25(8):1003-5. PubMed ID: 20142464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incomplete Sjögren-Larsson syndrome in two Japanese siblings.
    Kawakami T; Saito R; Fujikawa Y; Kazama H; Shinomiya N; Yamaguchi K; Yamaguchi Y; Aoki T; Kobayashi T
    Dermatology; 1999; 198(1):93-6. PubMed ID: 10026413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatty alcohol metabolism in cultured human fibroblasts. Evidence for a fatty alcohol cycle.
    Rizzo WB; Craft DA; Dammann AL; Phillips MW
    J Biol Chem; 1987 Dec; 262(36):17412-9. PubMed ID: 3320042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel assay for the prenatal diagnosis of Sjögren-Larsson syndrome.
    van den Brink DM; van Miert JM; Wanders RJ
    J Inherit Metab Dis; 2005; 28(6):965-9. PubMed ID: 16435189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton magnetic resonance spectroscopy findings and clinical effects of montelukast sodium in a case with Sjögren-Larsson syndrome.
    Pirgon O; Aydin K; Atabek ME
    J Child Neurol; 2006 Dec; 21(12):1092-5. PubMed ID: 17156709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosing Sjögren-Larsson syndrome in a 7-year-old Moroccan boy.
    Bernardini ML; Cangiotti AM; Zamponi N; Porfiri L; Cinti S; Offidani A
    J Cutan Pathol; 2007 Mar; 34(3):270-5. PubMed ID: 17302612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sjögren-Larsson syndrome: a rare disease of the skin and central nervous system.
    Roy U; Das U; Pandit A; Debnath A
    BMJ Case Rep; 2016 Apr; 2016():10.1136/bcr-2016-215110. PubMed ID: 27095813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sjögren-Larsson syndrome: A biochemical rationale for using aldehyde-reactive therapeutic agents.
    Rizzo WB; S'aulis D; Dorwart E; Bailey Z
    Mol Genet Metab Rep; 2022 Mar; 30():100839. PubMed ID: 35242571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase. Sensitivity to fatty aldehydes and Schiff's base modification of phospholipids: implications for Sj-ogren-Larsson syndrome.
    James PF; Zoeller RA
    J Biol Chem; 1997 Sep; 272(38):23532-9. PubMed ID: 9295289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatty alcohol accumulation in the autosomal recessive form of rhizomelic chondrodysplasia punctata.
    Rizzo WB; Craft DA; Judd LL; Moser HW; Moser AB
    Biochem Med Metab Biol; 1993 Aug; 50(1):93-102. PubMed ID: 8373640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.